David Simon | Twin Capital | Blogspot
Twin Capital Hedge Fund Manager
Wednesday, September 26, 2018
Muhlenberg Institute of Public Opinion Ranks as Top College Pollster
As Managing Member of Twin Capital Management, LLC, David Simon is a leading New York City-based investment professional. Before founding Twin Capital more than 30 years ago, David Simon completed degrees at the University of Miami School of Law and Muhlenberg College, where he graduated magna cum laude.
Situated just one hour from Philadelphia and an hour and a half from New York City, Muhlenberg College is a well-known liberal arts college in Allentown, Pennsylvania. An interesting feature of the College is its polling center, which is called the Institute of Public Opinion.
Rated by FiveThirtyEight's Nate Silver as the No.1 college polling service in the country, Muhlenberg’s Institute of Public Opinion is also ranked ahead of many national news and network polling services, attaining the number 10 spot overall nationwide. Giving students lots of exposure to political campaigning and the role of public opinion in shaping policy, the Institute's polls are run in the field by Muhlenberg students.
Friday, September 7, 2018
Brave Gowns Inspire and Comfort Children in Hospitals
Investment advisor and philanthropist David Simon established Twin Capital Management, LLC, 30 years ago. Today, Twin Capital provides investors with numerous opportunities in the alternative investment and hedge fund arenas. Among David Simon’s charitable endeavors was co-founding the Starlight Children’s Foundation annual Westchester golf outing. Starlight Children’s Foundation works to provide children in hospitals with fun and laughter through carefully designed outreach projects and partnerships.
In 2016, Starlight Children’s Foundation began its Brave Gowns initiative. This program aims to make hospital stays less impersonal and frightening for children by giving them hospital gowns created to look like the costumes worn by superheroes, princesses, astronauts, and other characters they love.
The project is based on an idea from an entrepreneur who lost her brother to a terminal illness. Wanting to make things better for other children engaged in similar battles, she created an entirely new kind of gown for them. Brave Gowns provide more comfort and privacy than standard-issue hospital gowns while still allowing for the various medical procedures that need to be performed. And because they are so packed with personality, they let each child’s own superhero nature shine through.
Brave Gowns have drawn increasing media attention, and several hospitals have even adopted them as their standard gowns for child patients. To date, Starlight Children’s Foundation gowns based on the Brave Gowns design have reached approximately 150,000 children across the country.
Sources:
https://www.starlight.org/starlight-programs/starlight-gowns/
https://www.bravegowns.com/
In 2016, Starlight Children’s Foundation began its Brave Gowns initiative. This program aims to make hospital stays less impersonal and frightening for children by giving them hospital gowns created to look like the costumes worn by superheroes, princesses, astronauts, and other characters they love.
The project is based on an idea from an entrepreneur who lost her brother to a terminal illness. Wanting to make things better for other children engaged in similar battles, she created an entirely new kind of gown for them. Brave Gowns provide more comfort and privacy than standard-issue hospital gowns while still allowing for the various medical procedures that need to be performed. And because they are so packed with personality, they let each child’s own superhero nature shine through.
Brave Gowns have drawn increasing media attention, and several hospitals have even adopted them as their standard gowns for child patients. To date, Starlight Children’s Foundation gowns based on the Brave Gowns design have reached approximately 150,000 children across the country.
Sources:
https://www.starlight.org/starlight-programs/starlight-gowns/
https://www.bravegowns.com/
Wednesday, August 8, 2018
SKC Appoints First Trials Coordinator for Neuroblastoma
David Simon is the managing member, the CEO, and Co-Chief Investment Officer of Twin Capital Management, LLC. Outside of his professional life, David Simon of Twin Capital supports Solving Kids’ Cancer (SKC), which supports and provides information to families of children with neuroblastoma.
In a bid to help children with neuroblastoma access life-saving trials faster, SKC recently appointed Dr. Emmanouela Gbandi as trials coordinator for neuroblastoma. It is the first appointment specifically dedicated to a single childhood cancer.
More clinical trials are needed for children with neuroblastoma. This will help in the development of life-saving therapies and an increased understanding of the disease. However, because neuroblastoma is rare, research programs conducted around the world are done in isolation.
Dr. Gbandi’s role will involve bringing together researchers, hospitals, and pharmaceutical companies, harmonizing efforts toward finding effective treatments for curing or reducing the symptoms of neuroblastoma. She will develop specialist knowledge of the disease, identify synergies between trials, and highlight problems quickly. By fostering integrative work and collaboration, better trials can be designed, increasing their likelihood of success.
Friday, July 20, 2018
Alumni Network at University of Miami School of Law Builds Community
In 1988, David Simon established Twin Capital Management, LLC, in New York City, where he is the Chief Executive Officer, Co-Chief Investment Officer, and Managing Member. In addition to his longtime career as an investment manager, David Simon is a magna cum laude graduate of the University of Miami School of Law, where he served as a member of the Law Review.
The University of Miami School of Law maintains a strong connection to its alumni community, offering multiple channels for ongoing engagement. The school’s Office of Development and Alumni Relations provides meaningful volunteer opportunities, such as participation in the Coffee Connectors Network.
The Coffee Connectors Network facilitates practical actions on the part of alumni that can help to jump-start the careers of young professionals. The assistance can be as simple as forwarding a resume or serving as a sounding board over a cup of coffee.
Interested alumni can fill out an online application, specifying whether they would like to engage in jobs and internships, speak with prospective students about the university’s programs, assist with fundraising, or pursue other opportunities to keep alumni connections strong.
Monday, July 16, 2018
Solving Kids' Cancer Celebrates Passage of STAR Act
David Simon serves as the Chief Investment Officer and Managing Member of Twin Capital Management, LLC. Outside of his work, David Simon supports various charities focused on the common good, including Solving Kids' Cancer.
A New York City-based organization, Solving Kids' Cancer supports research into aggressive childhood cancers. Recently, Solving Kids’ Cancer celebrated the passage of the federal STAR (Survivorship, Treatment, Access, and Research) Act, which enables the collection of medical specimens of certain youth cancer patients to better understand how to treat the cancers. Specimen collection will be overseen by the National Institutes of Health.
The STAR Act also provides funding for the Centers for Disease Control and Prevention to award grants for the purpose of tracking childhood cancers and treatments. Hailing the bill’s passage as the result of a cooperative effort that required years of planning and patience, Solving Kids’ Cancer recognized other groups for their successful lobbying efforts, including the Coalition Against Childhood Cancer and the Alliance for Childhood Cancer.
Tuesday, July 3, 2018
Muhlenberg College Undergraduate Business Study Abroad Options
David Simon is the CIO and Managing Member of Twin Capital Management, a New York-based alternative investment company with a consistent record of positive returns. To prepare for his career, David Simon graduated magna cum laude from both the University of Miami School of Law and Muhlenberg College, where he earned a bachelor’s degree in accounting and finance.
One of the preeminent liberal arts colleges in the United States, Muhlenberg College offers over 40 majors and a varied curriculum to more than 2,000 students. Located near Allentown, Pennsylvania, the college’s rich tradition dates back to its founding 180 years ago.
Muhlenberg College brings its unique holistic approach to all of its courses, including the accounting, business, and economics (ABE) program, which integrates liberal arts traditions and critical thinking skills into a rigorous business curriculum. In addition to classes taught by prominent faculty members, the college’s ABE students have the opportunity to participate in a special study abroad program.
Conducted in partnership with the Center for European Studies at the University of Maastricht in the Netherlands, the program offers courses in business, economics, and politics taught in English. Additionally, students have the opportunity to travel throughout northern and central Europe during their visits.
Saturday, June 2, 2018
Applying for a Grant from Solving Kids’ Cancer
As the managing member of Twin Capital Management, David Simon draws upon more than three decades of experience in risk arbitrage, special situation investing, as well as, corporate law. Outside of his accomplishments in the investment field, David Simon supports numerous nonprofit and charitable organizations, including Solving Kids’ Cancer.
Founded by two fathers who lost their children to cancer, Solving Kids’ Cancer is a nonprofit group devoted to supporting research into innovative treatments for rare pediatric cancers. Since its founding, the organization has identified and funded dozens of clinical studies on cutting-edge treatments such as precision medicine, high-intensity focused ultrasound, targeted small molecules, and more.
Solving Kids’ Cancer invites researchers working on pediatric cancer to apply for funding from the organization. Grants range from $50,000 to $600,000 and are most often awarded to clinical researchers focusing on early-phase clinical studies with a high rate of risk and return. Additionally, projects focusing on novel therapies receive priority during the grant-review process.
Grant proposals must be written in English, and the proposed budget can allocate no more than 15 percent to 20 percent of the funding to personnel costs. To learn more about applying for a grant from Solving Kids’ Cancer, please visit SolvingKidsCancer.org/Apply-for-a-Research-Grant.
Subscribe to:
Posts (Atom)